Polysubstance dependence

Last updated
Polysubstance dependence
Psychoactive Drugs.jpg
Psychoactive substances
Specialty Psychiatry
Symptoms Frequent poly drug use
Complications Combined drug intoxication, drug overdose

Polysubstance dependence refers to a type of substance use disorder in which an individual uses at least three different classes of substances indiscriminately and does not have a favorite substance that qualifies for dependence on its own. Although any combination of three substances can be used, studies have shown that alcohol is commonly used with another substance. [1] This is supported by one study on polysubstance use that separated participants who used multiple substances into groups based on their preferred substance. The results of a longitudinal study on substance use led the researchers to observe that excessively using or relying on one substance increased the probability of excessively using or relying on another substance. [2]

Contents

Common combinations

The three substances were cocaine, alcohol, and heroin, which implies that those three are very popular. [3] Other studies have found that opiates, cannabis, amphetamines, hallucinogens, inhalants, and benzodiazepines are often used in combination as well. [4]

Presentation

Associated cognitive impairments

Cognition refers to what happens in the mind, such as mental functions like "perception, attention, memory, language, problem solving, reasoning, and decision making." [5] Although many studies have looked at the cognitive impairments of individuals who are dependent on one substance, there are few researchers who have tried to determine the problems with cognitive functioning that are caused by dependence on multiple substances. [6] Therefore, what is known about the effects of polysubstance dependence on mental abilities is based on the results of a few studies.

Brain headBorder.jpg

Learning ability

The effect of polysubstance dependence on learning ability is one area of interest to researchers. A study involving 63 polysubstance dependent women and 46 controls (participants who were not using substances) used the Benton Visual Retention Test (BVRT) and the California Verbal Learning Test (CVLT) to look at visual memory and verbal ability. [7] This study showed that in polysubstance dependent women, verbal learning ability was significantly decreased, though visual memory was not affected. In addition, alcohol and cocaine use led to more severe issues with verbal learning, recall, and recognition. [7]

Memory, reasoning and decision making

Sometimes studies about specific groups in the general population can be informative. One study decided to test the cognitive abilities of participants in rave parties who used multiple substances. To do this, they compared 25 rave party attenders with 27 control participants who were not using substances. The results of this study indicated that in general, the rave attender group did not perform as well on tasks that tested speed of information processing, working memory, knowledge of similarities between words, ability to attend to a task with interference in the background, and decision making. [3] Certain substances were associated with particular mental functions, but the researchers suggested that the impairments for working memory and reasoning were caused by the misuse of multiple substances. [3]

Another study that tried to find differences between the effects of particular substances focused on people with polysubstance use who were seeking treatment for addictions to cannabis, cocaine, and heroin. They studied a group of people with polysubstance use and a group that was not dependent on any substances. Because alcohol was a common co-substance for nearly all of the people in the polysubstance use group, it was difficult to tell exactly which substances were affecting certain cognitive functions. The researchers found that the difference in the two groups' performance levels on executive function, or higher-level cognitive processing tasks were consistently showing that the polysubstance group scored lower than the control group. [8] In general, this meant that multiple substances negatively affected the polysubstance group's cognitive functioning. More specifically, the researchers found that the amount of cannabis and cocaine affected the verbal part of working memory, the reasoning task, and decision making, while cocaine and heroin had a similar negative effect on visual and spatial tasks, but cannabis particularly affected visual and spatial working memory. [8] These results suggest that the combined use of cannabis, cocaine, and heroin impair more cognitive functions more severely than if used separately. [8]

Alcohol's negative effects on learning, spatial abilities and memory has been shown in many studies. [9] This raises a question: does using alcohol in combination with other substances impair cognitive functioning even more? One study decided to try to determine if people with polysubstance use who also recreationally use alcohol would display poorer performance on a verbal learning and memory test in comparison to those who consumed excessive amounts of alcohol specifically. [10] The California Verbal Learning Test (CVLT) was used due to its ability to "quantify small changes in verbal learning and memory" by evaluating errors made during the test and the strategies used to make those errors. [10] The results of this study showed that the group of people with polysubstance and alcohol use performed poorly on the CVLT recall and recognition tests compared to the group of people who exclusively consumed excessive alcohol only, which implies that polysubstance use impaired the memory and learning in a different way than the effects of alcohol alone can explain. [10]

Length of abstinence matter

To examine whether abstinence for long periods of time helps people with polysubstance use recover their cognitive function, a group of researchers tested 207 polysubstance dependent men, of whom 73.4% were dependent on three or more substances. [6] The researchers were interested in six areas of cognitive functioning, which included visual memory, verbal memory, knowledge of words, abstract reasoning, inhibition (interference), and attention. [6] The study used the Benton Visual Retention Test (BVRT) for testing visual memory, the California Verbal Learning Test (CVLT) for verbal memory, the Wechsler Adult Intelligence Scale vocabulary portion for knowledge of words, the Booklet Category Test for abstract reasoning, the Stroop Neuropsychological Screening task for inhibition, and the Trail Making Test for attention. [6] The results showed that neuropsychological ability did not improve with increases in the length of time abstinent. This suggests that polysubstance dependence leads to serious impairment which cannot be recovered much over the span of a year. [6]

Causes

Biological

Chemical synapse schema cropped.jpg

There is data to support that some genes contribute to substance dependence. [11] Some studies have focused on finding genes that predispose the person to be dependent on marijuana, cocaine, or heroin by studying genes that control a person's dopamine and opioid receptors, but no conclusive findings were reported. [12] Other researchers found a connection between dopamine receptor genes and dependency on a substance. [12] A potential problem with this study was that alcohol is commonly used with another substance, so the results of the study may not have been caused by dependency on a single substance. This means that multiple substances may have been contributing to the results, but the researchers suggested that further research should be done. [12]

However, there are studies that have found evidence of the influence of genes on vulnerability to substance dependence. [13] These studies often use genotype, or the genetic information found on a person's chromosomes, and phenotype, which consists of the visible features of a person, to look at genetic patterns. [14] One study examined the phenotype and genotype of 1,858 participants from 893 families to look at differences in three nicotinic acetylcholine receptor genes found within these individuals. [13] The experimenters found significant connections between receptor genes for nicotine and polysubstance dependence, which indicated that differences in these genes can create the risk of being dependent on multiple substances. [13]

Psychological

A 1985 study conducted by Khantzian and Treece found that 65% of their opioid-dependent sample met criteria for a personality disorder diagnosis. In the same study, 93% of the sample had a comorbid disorder, implying that the comorbid disorder plays some role in the addiction. [15] [16] It has also been shown that depression and polysubstance dependence are often both present at the same time. If a person is genetically predisposed to be depressed then they are at a higher risk of having polysubstance dependence. [17]

Possibly the most widely accepted cause of addictions is the self-medication hypothesis, that views substance addiction as a form of coping with stress through negative reinforcement, by temporarily alleviating awareness of or concerns over the stressor. [18] People who use substances learn that the effects of each type of substance works to relieve or better painful states. They use substances as a form of self-medication to deal with difficulties of self-esteem, relationships, and self-care. Individuals with substance use disorders often are overwhelmed with emotions and painful situations and turn to substances as a coping method. [19]

Sociocultural

The sociocultural causes are areas in a person's life that might have influenced their decision to start and continue using multiple substances. Sociocultural causes can be divided into social causes and cultural causes.

In the older generations, polysubstance dependence had been linked to additional considerations such as personality disorder, homelessness, bipolar disorder, major depressive disorder and so on. Medical care being so expensive and difficult to get long term has been linked to polysubstance dependence. Those who need psychological help sometimes use multiple substances as a type of self medication to help manage their mental illnesses. [20]

Comorbidity of mental disorders

For most of these disorders, in relation to polysubstance dependence, there is a vicious cycle that those with a dependence go through. First, ingesting the substance creates a need for more, which creates a dopamine surge, which then creates pleasure. As the dopamine subsides, the pleasure adds to the emotional and physical pain and triggers stress transmitters, which in turn creates a craving, which must then be medicated, and thus the cycle begins again. However, the next time they use, more of the substance will need to be used to get to the same degree of intoxication . [21] [22]

Depression

Scientists have hypothesized that the use of a substance either causes a mood disorder such as depression or at least attributes to a pre-existing one. Additionally, the substances that people with depression use can be a misguided method of self-medication in order to manage their depression. [23] This is the classic chicken or egg hypothesis, does the pre-existing condition cause dependence or does dependence cause the condition? The underlying mental illness needs to be identified and treated in conjunction with treating the polysubstance dependence in order to increase the success rate of treatment and decrease the probability of relapse. [17] One specific study focused on alcohol and depression, because they are so commonly inter-related. Researchers have discovered that depression continues for several weeks after a patient had been rehabilitated and those who relapsed developed depression again. This means that the onset of depression happens after alcohol dependence occurs, which means that alcohol is a major contributor to depression. [17]

Eating disorders

One study showed that patients who are recovering from an addiction, who have had an eating disorder in the past, often use food to try to replace the substance that they are no longer getting. Or they obsess over controlling their weight and appearance. Some rehabilitation centers have licensed nutritionists to help patients develop healthy eating habits to help them cope while recovering from their addictions. It is important that those who have a former eating disorder be taught how to eat healthfully, so they don't continuously switch from one addiction back to another. [22]

Diagnosis

According to the DSM-IV, a diagnosis of polysubstance dependence must include a person who has used at least three different substances (not including caffeine or nicotine) indiscriminately, but does not have a preference to any specific one. In addition they must show a minimum of three of the following symptoms listed below, all within the past twelve months. [24] There is a distinct difference between a person having three separate dependence issues and having Polysubstance dependence the main difference is polysubstance dependence means that they are not specifically addicted to one particular substance. This is often confused with multiple specific dependences present at the same time. To elaborate, if a person is addicted to three separate substance such as cocaine, methamphetamines and alcohol and is dependent on all three then they would be diagnosed with three separate dependence disorders existing together (cocaine dependence, methamphetamine dependence and alcohol dependence,) not polysubstance dependence. [24] In addition to using three different substances without a preference to one, there has to be a certain level of dysfunction in a person's life to qualify for a diagnosis of polysubstance dependence. [25] One of the bigger challenges that often occurs when trying to diagnose is the fact that people don't always report what they are taking because they are afraid of getting into legal trouble. [20] When coding polysubstance Dependence in a DSM-IV it would be a multiaxial diagnosis 304.80- Polysubstance Dependence", next to the classification, it is accompanied by a list of other types of Substance dependence (e.g. "305.00 Alcohol Abuse" or "305.60 Cocaine Abuse"). [26]

The DSM-IV requires at least three of the following symptoms present during a 12-month period for a diagnoses of polysubstance dependence. [27]

DSM-5 eliminated polysubstance disorder; there the substances must be specified, among other related changes. [28]

Treatment

Treatment for polysubstance dependence has many critical aspects. Substance rehabilitation is a lengthy and difficult process. Treatment must be individualized and last a sufficient amount of time to ensure the patient has kicked the addictions and to ensure the prevention of relapse. The most common forms of treatment for polysubstance dependence include: inpatient and outpatient treatment centers, counseling and behavioral treatments, and medications. It is important that treatments be carried on throughout the patient's life in order to prevent relapse. It is a good idea that recovering addicts continue to attend social support groups or meet with counselors to ensure they do not relapse. [29]

Inpatient treatment center

Inpatient treatment centers are treatment centers where addicts move to the facility while they are undergoing treatment. Inpatient treatment centers offer a safe environment where patients will not be exposed to potentially harmful situations during their treatments as they would on the outside. Inpatients usually undergo the process of detoxification. Detox involves withdrawing the user (usually medically) from all substances of concern. During their stay in the treatment facility, patients often are learning to manage and identify their substance addictions and to find alternate ways to cope with whatever is the cause of their addiction. [30]

Outpatient treatments

Outpatient treatments include many of the same activities offered in an inpatient treatment facility, [31] but the patient is not protected by the secure and safe environment of an inpatient treatment center. For this reason, they are significantly less effective. The patient usually continues to hold a job and goes to treatment nightly. [30]

Twelve-step programs

Both in-patient and out-patient treatments can offer introductions to Twelve-step programs such as Alcoholics Anonymous and Narcotics Anonymous. They offer regular meetings where members can discuss their experiences in a non-judgmental and supportive place. [32]

Cognitive behavioral therapy

Also offered to patients are one-on-one counseling sessions and cognitive behavioral therapy (CBT). [30] When looked at through a cognitive-behavioral perspective, addictions are the result of learned behaviors developed through positive experiences. In other words, when an individual uses a substance and receives desired results (happiness, reduced stress, etc.) it may become the preferred way of attaining those results, leading to addictions. The goal of CBT is to identify the needs that the addictions are being used to meet and to develop skills and alternative ways of meeting those needs. The therapist will work with the patient to educate them on their addictions and give them the skills they need to change their cognitions and behaviors. Addicts will learn to identify and correct problematic behavior. They will be taught how to identify harmful thoughts and substance cravings. CBT is an effective treatment for addictions. [33]

Medications

Medications can be very helpful in the long-term treatment of polysubstance dependence. Medications are a useful aid in helping to prevent or reducing substance cravings. Another benefit of medications is helping to preventing relapse. Since substance use disorders affect brain functioning, medications assist in returning to normal brain functioning. People who use multiple substances require medications for each substance they use, as the current medications do not treat all substance use disorders simultaneously. Medications are a useful aid in treatments, but are not effective when they are the sole treatment method. [29]

Substance use Disorder Medications

Epidemiology

There are not very many studies that have examined how often polysubstance dependence occurs or how many people are dependent on multiple substances. However, according to a study that analyzed the results from the National Epidemiological Survey on Alcohol and Related Conditions, approximately 215.5 out of a total of 43,093 individuals in the United States (0.5%) met the requirements for polysubstance use disorder. [36] Another study suggested that the number of new cases of polysubstance dependence has been going up. [37] This idea was supported by a study that took place in Munich, Germany. A group of researchers chose to look at responses to a survey using the M-Composite International Diagnostic Interview (M-CIDI). The M-CIDI is a version of the Composite International Diagnostic Interview (CIDI). [38] The researchers collected data from 3,021 participants, all between the ages of 14 and 24, to estimate the prevalence, or total number of cases, of substance use and of polysubstance use/dependence. [39] The results of this study indicated that of the 17.3% who said that they regularly used substances, 40% said that they used more than one substance, but 3.9% specifically reported using three or more substances, indicating that there is a lot of overlap in the use of different substances. [39] The researchers compared their results to earlier German studies and found that substance dependence seems to be increasing, at least in Germany. [39]

Gender differences

Women and men differ in various ways when it comes to addictions. Research has shown that women are more likely to be polysubstance dependent. It has been noted that a larger percentage of women use licit (legal) substances such as tranquilizers, sedatives, and stimulants. On the other hand, men are more likely to use illicit (illegal) substances such as cocaine, methamphetamine, and other illicit substances. Research suggests that women addicts more frequently have a family history of substance use. When asked to describe their onset of addictions, women more frequently describe their addiction as sudden where as men describe them as gradual. Females have a higher percentage of fatty tissues and a lower percentage of body water than men. Therefore, women absorb substances more slowly. This means these substances are at a higher concentration in a woman's bloodstream. Female addicts are known to be at greater risk for fatty liver disease, hypertension, anemia, and other disorders. [40]

See also

Related Research Articles

<span class="mw-page-title-main">Substance abuse</span> Harmful use of drugs

Substance abuse, also known as drug abuse, is the use of a drug in amounts or by methods that are harmful to the individual or others. It is a form of substance-related disorder. Differing definitions of drug abuse are used in public health, medical, and criminal justice contexts. In some cases, criminal or anti-social behavior occurs when the person is under the influence of a drug, and long-term personality changes in individuals may also occur. In addition to possible physical, social, and psychological harm, the use of some drugs may also lead to criminal penalties, although these vary widely depending on the local jurisdiction.

<span class="mw-page-title-main">Alcohol abuse</span> Substance abuse of alcoholic beverages

Alcohol abuse encompasses a spectrum of alcohol-related substance abuse, ranging from the consumption of more than 2 drinks per day on average for men, or more than 1 drink per day on average for women, to binge drinking or alcohol use disorder.

Drug rehabilitation is the process of medical or psychotherapeutic treatment for dependency on psychoactive substances such as alcohol, prescription drugs, and street drugs such as cannabis, cocaine, heroin or amphetamines. The general intent is to enable the patient to confront substance dependence, if present, and stop substance misuse to avoid the psychological, legal, financial, social, and physical consequences that can be caused.

<span class="mw-page-title-main">Alcohol dependence</span> Medical condition

Alcohol dependence is a previous psychiatric diagnosis in which an individual is physically or psychologically dependent upon alcohol.

<span class="mw-page-title-main">Opioid use disorder</span> Medical condition

Opioid use disorder (OUD) is a substance use disorder characterized by cravings for opioids, continued use despite physical and/or psychological deterioration, increased tolerance with use, and withdrawal symptoms after discontinuing opioids. Opioid withdrawal symptoms include nausea, muscle aches, diarrhea, trouble sleeping, agitation, and a low mood. Addiction and dependence are important components of opioid use disorder.

Substance dependence, also known as drug dependence, is a biopsychological situation whereby an individual's functionality is dependent on the necessitated re-consumption of a psychoactive substance because of an adaptive state that has developed within the individual from psychoactive substance consumption that results in the experience of withdrawal and that necessitates the re-consumption of the drug. A drug addiction, a distinct concept from substance dependence, is defined as compulsive, out-of-control drug use, despite negative consequences. An addictive drug is a drug which is both rewarding and reinforcing. ΔFosB, a gene transcription factor, is now known to be a critical component and common factor in the development of virtually all forms of behavioral and drug addictions, but not dependence.

State-dependent memory or state-dependent learning is the phenomenon where people remember more information if their physical or mental state is the same at time of encoding and time of recall. State-dependent memory is heavily researched in regards to its employment both in regards to synthetic states of consciousness as well as organic states of consciousness such as mood. While state-dependent memory may seem rather similar to context-dependent memory, context-dependent memory involves an individual's external environment and conditions while state-dependent memory applies to the individual's internal conditions.

<span class="mw-page-title-main">Polysubstance use</span> Use of multiple psychoactive substances

Polysubstance use or poly drug use refers to the use of combined psychoactive substances. Polysubstance use may be used for entheogenic, recreational, or off-label indications, with both legal and illegal substances. In many cases one drug is used as a base or primary drug, with additional drugs to leaven or compensate for the side effects, or tolerance, of the primary drug and make the experience more enjoyable with drug synergy effects, or to supplement for primary drug when supply is low.

Dual diagnosis is the condition of having a mental illness and a comorbid substance use disorder. There is considerable debate surrounding the appropriateness of using a single category for a heterogeneous group of individuals with complex needs and a varied range of problems. The concept can be used broadly, for example depression and alcohol use disorder, or it can be restricted to specify severe mental illness and substance use disorder, or a person who has a milder mental illness and a drug dependency, such as panic disorder or generalized anxiety disorder and is dependent on opioids. Diagnosing a primary psychiatric illness in people who use substances is challenging as substance use disorder itself often induces psychiatric symptoms, thus making it necessary to differentiate between substance induced and pre-existing mental illness.

Cocaine dependence is a neurological disorder that is characterized by withdrawal symptoms upon cessation from cocaine use. It also often coincides with cocaine addiction which is a biopsychosocial disorder characterized by persistent use of cocaine and/or crack despite substantial harm and adverse consequences. The Diagnostic and Statistical Manual of Mental Disorders, classifies problematic cocaine use as a "Stimulant use disorder". The International Classification of Diseases, includes "Cocaine dependence" as a classification (diagnosis) under "Disorders due to use of cocaine".

Post-acute withdrawal syndrome (PAWS) is a hypothesized set of persistent impairments that occur after withdrawal from alcohol, opiates, benzodiazepines, antidepressants, and other substances. Infants born to mothers who used substances of dependence during pregnancy may also experience a PAWS. While PAWS has been frequently reported by those withdrawing from opiate and alcohol dependence, the research has limitations. Protracted benzodiazepine withdrawal has been observed to occur in some individuals prescribed benzodiazepines.

Behavioral addiction, process addiction, or non-substance-related disorder is a form of addiction that involves a compulsion to engage in a rewarding non-substance-related behavior – sometimes called a natural reward – despite any negative consequences to the person's physical, mental, social or financial well-being. In the brain's reward system, a gene transcription factor known as ΔFosB has been identified as a necessary common factor involved in both behavioral and drug addictions, which are associated with the same set of neural adaptations.

<span class="mw-page-title-main">Substance use disorder</span> Continual use of drugs (including alcohol) despite detrimental consequences

Substance use disorder (SUD) is the persistent use of drugs despite the substantial harm and adverse consequences to one's own self and others, as a result of their use. In perspective, the effects of the wrong use of substances that are capable of causing harm to the user or others, have been extensively described in different studies using a variety of terms such as substance use problems, problematic drugs or alcohol use, and substance use disorder. The National Institute of Mental Health (NIMH) states that "Substance use disorder (SUD) is a treatable mental disorder that affects a person's brain and behavior, leading to their inability to control their use of substances like legal or illegal drugs, alcohol, or medications. Symptoms can be moderate to severe, with addiction being the most severe form of SUD". Substance use disorders (SUD) are considered to be a serious mental illness that fluctuates with the age that symptoms first start appearing in an individual, the time during which it exists and the type of substance that is used. It is not uncommon for those who have SUD to also have other mental health disorders. Substance use disorders are characterized by an array of mental/emotional, physical, and behavioral problems such as chronic guilt; an inability to reduce or stop consuming the substance(s) despite repeated attempts; operating vehicles while intoxicated; and physiological withdrawal symptoms. Drug classes that are commonly involved in SUD include: alcohol (alcoholism); cannabis; opioids; stimulants such as nicotine, cocaine and amphetamines; benzodiazepines; barbiturates; and other substances.

Polysubstance was used in the American Psychiatric Association's Diagnostic and Statistical Manual for Mental Disorders to refer to three or more drugs to which an individual has become dependent. The criteria were changed in the DSM-5. In the DSM-IV nosology, polysubstance dependence indicated that the use of any one of the substances did not meet the diagnostic criteria for substance dependence while the combined use of the drugs did meet substance dependence diagnostic criteria.

<span class="mw-page-title-main">Addiction</span> Disorder resulting in compulsive behaviours

Addiction is a neuropsychological disorder characterized by a persistent and intense urge to use a drug or engage in a behaviour that produces natural reward, despite substantial harm and other negative consequences. Repetitive drug use often alters brain function in ways that perpetuate craving, and weakens self-control. This phenomenon – drugs reshaping brain function – has led to an understanding of addiction as a brain disorder with a complex variety of psychosocial as well as neurobiological factors that are implicated in addiction's development. Classic signs of addiction include compulsive engagement in rewarding stimuli, preoccupation with substances or behavior, and continued use despite negative consequences. Habits and patterns associated with addiction are typically characterized by immediate gratification, coupled with delayed deleterious effects.

<span class="mw-page-title-main">Cannabis use disorder</span> Continued use of cannabis despite clinically significant impairment

Cannabis use disorder (CUD), also known as cannabis addiction or marijuana addiction, is a psychiatric disorder defined in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and ICD-10 as the continued use of cannabis despite clinically significant impairment.

About 1 in 7 Americans suffer from active addiction to a particular substance. Addiction can cause physical, psychological, and emotional harm to those who are affected by it. The American Society of Addiction Medicine defines addiction as "a treatable, chronic medical disease involving complex interactions among brain circuits, genetics, the environment, and an individual's life experiences. People with addiction use substances or engage in behaviors that become compulsive and often continue despite harmful consequences." In the world of psychology and medicine, there are two models that are commonly used in understanding the psychology behind addiction itself. One model is referred to as the disease model of addiction. The disease model suggests that addiction is a diagnosable disease similar to cancer or diabetes. This model attributes addiction to a chemical imbalance in an individual's brain that could be caused by genetics or environmental factors. The second model is the choice model of addiction, which holds that addiction is a result of voluntary actions rather than some dysfunction of the brain. Through this model, addiction is viewed as a choice and is studied through components of the brain such as reward, stress, and memory. Substance addictions relate to drugs, alcohol, and smoking. Process addictions relate to non-substance-related behaviors such as gambling, spending money, sexual activity, gaming, spending time on the internet, and eating.

Relapse prevention (RP) is a cognitive-behavioral approach to relapse with the goal of identifying and preventing high-risk situations such as unhealthy substance use, obsessive-compulsive behavior, sexual offending, obesity, and depression. It is an important component in the treatment process for alcohol use disorder, or alcohol dependence. This model founding is attributed to Terence Gorski's 1986 book Staying Sober.

Edward Khantzian was a professor of psychiatry at Harvard Medical School. Beginning in the 1970s, he developed a progressively more coherent and empirically-grounded self-medication hypothesis of drug abuse, which states that individuals use drugs in an attempt to self-medicate states of distress and suffering.

Nancy M. Petry was a psychologist known for her research on behavioral treatments for addictive disorders, behavioral pharmacology, impulsivity and compulsive gambling. She was Professor of Medicine at the University of Connecticut Health Center. Petry served as a member of the American Psychiatric Association Workgroup on Substance Use Disorders for the DSM-5 and chaired the Subcommittee on Non-Substance Behavioral Addictions. The latter category includes Internet addiction disorder and problem gambling. She also served as a member of the Board of Advisors of Children and Screens: Institute of Digital Media and Child Development.

References

  1. Malcolm, Barris P.; Hesselbrock, Michie N.; Segal, Bernard (2006). "Multiple Substance Dependence and Course of Alcoholism among Alaska Native Men and Women". Substance Use & Misuse. 41 (5): 729–41. doi:10.1080/10826080500391803. PMID   16603457. S2CID   33406853.
  2. Newcomb, Michael D.; Galaif, Elisha R.; Locke, Thomas F. (2001). "Substance use diagnoses within a community sample of adults: Distinction, comorbidity, and progression over time". Professional Psychology: Research and Practice. 32 (3): 239–47. doi:10.1037/0735-7028.32.3.239.
  3. 1 2 3 Verdejo-García, Antonio; Pérez-García, Miguel (2006). "Profile of executive deficits in cocaine and heroin polysubstance users: Common and differential effects on separate executive components". Psychopharmacology. 190 (4): 517–30. doi:10.1007/s00213-006-0632-8. PMID   17136401. S2CID   38338649.
  4. Kornreich, Charles; Delle-Vigne, Dyna; Campanella, Salvatore; Noël, Xavier; Papageorgiou, Constantin; Brown, Olivier; Verbanck, Paul; Ermer, Elsa (2012). "Conditional reasoning difficulties in polysubstance-dependent patients". Psychology of Addictive Behaviors. 26 (3): 665–71. doi:10.1037/a0025841. PMID   21988481.
  5. Goldstein, E. Bruce (2008). "Cognitive psychology". Cognitive Psychology: Connecting Mind, Research, and Everyday Experience (2nd ed.). Belmont, CA: Wadsworth. p.  488. ISBN   978-0-495-09557-6.
  6. 1 2 3 4 5 Medina, K; Shear, PK; Schafer, J; Armstrong, TG; Dyer, P (2004). "Cognitive functioning and length of abstinence in polysubstance dependent men". Archives of Clinical Neuropsychology. 19 (2): 245–58. doi: 10.1016/S0887-6177(03)00043-X . PMID   15010089.
  7. 1 2 Medina KL, Shear PK, Schafer J (2006). "Memory functioning in polysubstance dependent women". Drug and Alcohol Dependence. 84 (3): 248–55. doi:10.1016/j.drugalcdep.2006.02.009. PMID   16595165.
  8. 1 2 3 Fernandez-Serrano, M. J.; Perez-Garcia, M.; Schmidt Rio-Valle, J.; Verdejo-Garcia, A. (2009). "Neuropsychological consequences of alcohol and drug abuse on different components of executive functions". Journal of Psychopharmacology. 24 (9): 1317–32. doi:10.1177/0269881109349841. PMID   20007413. S2CID   9084814.
  9. "Cognitive impairment and recovery from alcoholism". Alcohol Alert. National Institute on Alcohol Abuse and Alcoholism. July 2001.
  10. 1 2 3 Bondi, Mark W.; Drake, Angela I.; Grand, Igor (1998). "Verbal learning and memory in alcohol abusers and polysubstance abusers with concurrent alcohol abuse". Journal of the International Neuropsychological Society. 4 (4): 319–28. doi:10.1017/S1355617798003191. PMID   9656605. S2CID   26972526.
  11. Uhl, George R.; Liu, Qing-Rong; Walther, Donna; Hess, Judith; Naiman, Daniel (2001). "Polysubstance Abuse–Vulnerability Genes: Genome Scans for Association, Using 1,004 Subjects and 1,494 Single-Nucleotide Polymorphisms". American Journal of Human Genetics. 69 (6): 1290–300. doi:10.1086/324467. PMC   1235541 . PMID   11704927.
  12. 1 2 3 Reich, T; Hinrichs, A; Culverhouse, R; Bierut, L (1999). "Genetic Studies of Alcoholism and Substance Dependence". American Journal of Human Genetics. 65 (3): 599–605. doi:10.1086/302561. PMC   1377965 . PMID   10441565.
  13. 1 2 3 Sherva, Richard; Kranzler, Henry R; Yu, Yi; Logue, Mark W; Poling, James; Arias, Albert J; Anton, Raymond F; Oslin, David; et al. (2010). "Variation in Nicotinic Acetylcholine Receptor Genes is Associated with Multiple Substance Dependence Phenotypes". Neuropsychopharmacology. 35 (9): 1921–31. doi:10.1038/npp.2010.64. PMC   3055642 . PMID   20485328.
  14. Smith, Maree T. (September 2010). "Pharmacogenetics". Pain: Clinical Updates. 18 (8): 1–8. Archived from the original on 2020-05-31. Retrieved 2022-02-12.
  15. Khantzian, E. J.; Treece, C. (November 1985). "DSM-III psychiatric diagnosis of narcotic addicts. Recent findings". Archives of General Psychiatry. 42 (11): 1067–1071. doi:10.1001/archpsyc.1985.01790340045007. ISSN   0003-990X. PMID   4051684.
  16. Hall, Danny H.; Queener, John E. (2007). "Self-Medication Hypothesis of Substance Use: Testing Khantzian's Updated Theory". Journal of Psychoactive Drugs. 39 (2): 151–8. doi:10.1080/02791072.2007.10399873. PMID   17703709. S2CID   25558656.
  17. 1 2 3 Swendsen, J; Merikangas, KR (2000). "The comorbidity of depression and substance use disorders". Clinical Psychology Review. 20 (2): 173–89. doi:10.1016/S0272-7358(99)00026-4. PMID   10721496.
  18. Khantzian, Edward J. (18 September 2008). Understanding Addiction as Self Medication: Finding Hope Behind the Pain . Lanham, Maryland: Rowman & Littlefield Publishers. pp.  113. ISBN   978-0-7425-6137-3.
  19. Khantzian, Edward J. (1997). "The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications". Harvard Review of Psychiatry. 4 (5): 231–44. doi:10.3109/10673229709030550. PMID   9385000. S2CID   39531697.
  20. 1 2 3 Troncale, Joseph A. (May 2004). "Understanding dynamics of polysubstance dependence". Addiction Professionals.
  21. Johnson, Jayne. "The Addicted Brain". Boca Raton, Florida: Wellness Resource Center. Archived from the original on 2015-07-09. Retrieved 2013-05-23.[ unreliable medical source? ]
  22. 1 2 "Treatment Dual Diagnosis". Boca Raton, Florida: Wellness Resource Center. Archived from the original on 2015-07-09. Retrieved 2013-05-23.[ unreliable medical source? ]
  23. Abraham, Henry David; Fava, Maurizio (1999). "Order of onset of substance abuse and depression in a sample of depressed outpatients". Comprehensive Psychiatry. 40 (1): 44–50. doi:10.1016/S0010-440X(99)90076-7. PMID   9924877.
  24. 1 2 "Practice-Relevant Changes to the DSM-IV-TR: Clarification of Concept of Polysubstance Dependence". American Psychiatric Association . Retrieved 2012-07-05.
  25. American Psychiatric Association (2000). Quick reference to the diagnostic criteria from DSM-IV-TR . The American Psychiatric Association. ISBN   978-0-89042-026-3.[ page needed ]
  26. Skodol, Andrew E.; Oldham, John M.; Gallaher, Peggy E. (1999). "Axis II Comorbidity of Substance Use Disorders Among Patients Referred for Treatment of Personality Disorders". The American Journal of Psychiatry. 156 (5): 733–8. doi:10.1176/ajp.156.5.733. PMID   10327906. S2CID   22381423.
  27. 1 2 American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition: DSM-IV-TR. American Psychiatric Pub. pp.  293–4. ISBN   978-0-89042-025-6.
  28. "Highlights of Changes from DSM-IV-TR to DSM-5" (PDF). American Psychiatric Publishing. American Psychiatric Association. 2013. p. 16. The DSM-IV specifier for a physiological subtype has been eliminated in DSM-5, as has the DSM-IV diagnosis of polysubstance dependence.
  29. 1 2 "Treatment Approaches for Drug Addiction" (PDF). DrugFacts. National Institute on Drug Abuse. January 2019.
  30. 1 2 3 "What is Drug rehab?" drugrehab.org[ full citation needed ][ unreliable medical source? ]
  31. "Inpatient Rehab Facilities - Find Inpatient Rehab Near Me". Recovery.org. 2013-05-15. Retrieved 2020-11-13.
  32. Laudet, A.; Stanick, V.; Sands, B. (2007). "An Exploration of the Effect of On-Site 12-Step Meetings on Post-Treatment Outcomes among Polysubstance-Dependent Outpatient Clients". Evaluation Review. 31 (6): 613–46. doi:10.1177/0193841X07306745. PMC   2396509 . PMID   17986710.
  33. Kadden, Ronald M. (9 October 2002). "Cognitive-Behavior Therapy for Substance Dependence: Coping Skills Training" (PDF). Archived from the original (PDF) on 5 January 2012.[ unreliable medical source? ]
  34. Purvis, Andrew (11 December 1989). "Medicine: Can drugs cure drug addiction?". Time. Archived from the original on May 12, 2007.
  35. "Addiction Treatments Past and Present". Archived from the original on November 13, 2011.
  36. Agrawal, Arpana; Lynskey, Michael T.; Madden, Pamela A. F.; Bucholz, Kathleen K.; Heath, Andrew C. (2007). "A latent class analysis of illicit drug abuse/dependence: Results from the National Epidemiological Survey on Alcohol and Related Conditions". Addiction. 102 (1): 94–104. doi:10.1111/j.1360-0443.2006.01630.x. PMID   17207127.
  37. Suresh, Stelinas.D; Venkatesan, J (2008). "Substance dependence: Decades apart in a teaching hospital". Indian Journal of Psychiatry. 50 (2): 100–5. doi: 10.4103/0019-5545.42396 . PMC   2738335 . PMID   19742216.
  38. Schumann, A. (2001). "The association between degree of nicotine dependence and other health behaviours: Findings from a German general population study". The European Journal of Public Health. 11 (4): 450–2. doi: 10.1093/eurpub/11.4.450 . PMID   11766489.
  39. 1 2 3 Perkonigg, Axel; Lieb, Roselind; Wittchen, Hans-Ulrich (1998). "Prevalence of Use, Abuse and Dependence of Illicit Drugs among Adolescents and Young Adults in a Community Sample". European Addiction Research. 4 (1–2): 58–66. doi:10.1159/000018923. PMID   9740818. S2CID   46220739.
  40. Nelson-Zlupko, Lani; Kauffman, Eda; Dore, Martha Morrison (1995). "Gender differences in drug addiction and treatment: Implications for social work intervention with substance-abusing women". Social Work. 40 (1): 45–54. doi:10.1093/sw/40.1.45. PMID   7863372.